Quarterly report pursuant to Section 13 or 15(d)

Debt and Interest - Additional Information (Detail)

v2.4.0.8
Debt and Interest - Additional Information (Detail) (USD $)
3 Months Ended 3 Months Ended 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Mar. 31, 2014
Ovamed GmbH [Member]
Licensing Agreements [Member]
Mar. 31, 2014
Israel Discount Bank of New York [Member]
Mar. 31, 2014
IDB Promissory Note Payable [Member]
Feb. 13, 2014
IDB Promissory Note Payable [Member]
Mar. 31, 2014
Hercules Note Payable [Member]
Mar. 31, 2013
Hercules Note Payable [Member]
Feb. 13, 2014
Hercules Note Payable [Member]
Debt Instrument [Line Items]                    
Long-term Debt, Gross           $ 14,000,000 $ 14,000,000     $ 13,200,000
Debt Instrument, Periodic Payment               14,000,000    
Debt Instrument, Periodic Payment, Principal               13,200,000    
Debt Instrument Term Charges               400,000    
Debt Instrument, Fee Amount                   300,000
Debt Instrument, Periodic Payment, Interest               100,000    
Debt Instrument, Annual Principal Payment               500,000    
Debt Instrument, Face Amount         15,000,000          
Debt Instrument, Unused Borrowing Capacity, Amount             100,000      
Interest Expense, Debt 966,000 476,000       42,000   845,000 438,000  
Accretion of Discount               435,000 91,000  
Amortization of Debt Discount (Premium)               44,000 5,000  
Other Liabilities, Noncurrent $ 1,066,000   $ 1,077,000 $ 716,000            
Debt Instrument, Maturity Date           Feb. 13, 2016        
Debt Instrument, Interest Rate Terms The unpaid principal amount of each advance shall bear interest at a rate per annum equal to the rate payable on the Companys money market account of 0.75% plus a margin of 150 basis points.                  
Debt Instrument, Basis Spread on Variable Rate 0.75%                  
Debt Instrument, Description of Variable Rate Basis 150